Outlook Therapeutics, Inc.

Nasdaq:OTLK

Biological Products, (No Diagnostic Substances)·ISELIN, NJ

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/17/26	→
10-K	FY 2025	9/30/25	12/19/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-Q	Q4 2024	12/31/24	2/14/25	→
10-K/A	FY 2024	9/30/24	1/23/25	→
↓

Earnings Releases (8-K)

21 shown

Filed	Period
2/17/26	Q2 FY2026	→
12/19/25	Q1 FY2026	→
8/14/25	Q4 FY2025	→
5/15/25	Q3 FY2025	→
2/14/25	Q2 FY2025	→
12/27/24	Q1 FY2025	→
↓

News (8-K)

59 shown

Filed	Type	Description
3/5/26	Other	Other Events	→
2/18/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
2/11/26	Other	Other Events	→
1/2/26	Other	Other Events	→
11/13/25	Other	Other Events	→
11/3/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/26/26	ARS	ARS	→
5/23/25	424B5	424B5	→
5/22/25	424B5	424B5	→
5/14/25	424B3	424B3	→
5/14/25	424B3	424B3	→
3/28/25	424B3	424B3	→
↓

Filing History(771 filings)

TypeDateAccessionPeriodSize

8-K

Mar 5, 2026

0001104659-26-024189FORM 8-K

Mar 5, 2026

209.2 KB

8-K

Feb 18, 2026

0001104659-26-017118FORM 8-K

Feb 18, 2026

184.9 KB

10-Q

Feb 17, 2026

0001104659-26-01655410-Q

Dec 31, 2025

6.3 MB

8-K

Feb 17, 2026

0001104659-26-015887FORM 8-K

Feb 17, 2026

255.2 KB

8-K

Feb 11, 2026

0001104659-26-013470FORM 8-K

Feb 11, 2026

213.1 KB

SCHEDULE 13G/A

Feb 5, 2026

0001178913-26-000311

—

12.3 KB

ARS

Jan 26, 2026

0001140361-26-002408ARS

Sep 30, 2025

1.1 MB

DEFA14A

Jan 26, 2026

0001140361-26-002407DEFA14A

—

3.1 MB

DEF 14A

Jan 26, 2026

0001140361-26-002406DEF 14A

Mar 10, 2026

6.0 MB

8-K

Jan 2, 2026

0001104659-26-000066FORM 8-K

Dec 31, 2025

215.9 KB

10-K

Dec 19, 2025

0001104659-25-12326410-K

Sep 30, 2025

9.3 MB

8-K

Dec 19, 2025

0001104659-25-122786FORM 8-K

Dec 19, 2025

268.3 KB

8-K

Nov 13, 2025

0001104659-25-111316FORM 8-K

Nov 13, 2025

182.9 KB

8-K

Nov 3, 2025

0001104659-25-105633FORM 8-K

Nov 3, 2025

201.1 KB

SCHEDULE 13G/A

Oct 21, 2025

0000902664-25-004475

—

13.5 KB

Oct 3, 2025

0001649989-25-000010PRIMARY DOCUMENT

Oct 1, 2025

8.4 KB

Oct 3, 2025

0001649989-25-000009PRIMARY DOCUMENT

Oct 1, 2025

8.4 KB

Oct 3, 2025

0001649989-25-000008PRIMARY DOCUMENT

Oct 1, 2025

8.4 KB

Oct 3, 2025

0001649989-25-000007PRIMARY DOCUMENT

Oct 1, 2025

5.7 KB

Oct 3, 2025

0001649989-25-000006PRIMARY DOCUMENT

Oct 1, 2025

8.4 KB

Oct 3, 2025

0001649989-25-000005PRIMARY DOCUMENT

Oct 1, 2025

8.4 KB

Oct 3, 2025

0001649989-25-000004PRIMARY DOCUMENT

Oct 1, 2025

5.7 KB

Oct 3, 2025

0001649989-25-000003PRIMARY DOCUMENT

Oct 1, 2025

8.4 KB

8-K

Sep 29, 2025

0001104659-25-094558FORM 8-K

Sep 29, 2025

227.7 KB

8-K

Sep 5, 2025

0001104659-25-087886FORM 8-K

Sep 5, 2025

185.2 KB

25 filings shown

Outlook Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(771 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/21/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/31/25	SCHEDULE 13G	SCHEDULE 13G	→
5/28/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓